ALX Oncology reports Nature Medicine publication of ASPEN-06 phase 2 data
ALX Oncology said Nature Medicine published ASPEN-06 phase 2 clinical data on evorpacept in HER2-positive gastric cancer.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
ALX Oncology said Nature Medicine published ASPEN-06 phase 2 clinical data on evorpacept in HER2-positive gastric cancer.